novo nordisk wegovy weight loss

FDA, Novo Nordisk and diabetes drugs

Novo Nordisk Stock Rallies on Weight-Loss Retreat by Hims & Hers

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood about 17% lower at under $42.

Inc. on MSN · 3d

Novo’s Weight Loss Drugs Removed from FDA Shortage List

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and diabetes drugs,

The Associated Press on MSN · 1d

Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity treatments improve.

ABC30 Action News2d

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

The drugmaker Novo Nordisk can meet current and future ... Ozempic, for diabetes, and Wegovy, for weight loss, use the active ingredient semaglutide. All four drugs are part of a GLP-1 class ...

Weight-loss drugs are about to get a lot better

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

5don MSN

From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Are Weight Loss Injections Safe? What to Know Before Starting One

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results